It has recently been shown that minor subclones expressing interleukin 11 (IL11) and vascular endothelial growth factor D (VEGFD) within the primary tumor can modulate the immune system in a manner that enhances polyclonal metastatic growth of otherwise non-metastatic clones [171]. The gene discussed is VEGFD; the disease is neoplasm.